Our studies demonstrate that treatment of NSCLC cells with oligonucleotides encoding the VEGFq sequence inhibits cell growth and attenuates cell invasion through a mechanism involving inhibition of VEGF expression, downregulation of activated ERK 1/2 and AKT, and eventually induction of cell death. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.